menu ☰
menu ˟

[Department of Error] Department of Error

06 Jul 2019

Gazzard G, Konstantakopoulou E, Garway-Heath D, et al. Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial. Lancet 2019; 393: 1505–16—In this Article, the data for the laser trabeculoplasty group and the eye drops group were incorrectly switched in several places. The third paragraph of the Results section should have begun: “At 36 months, the selective laser trabeculoplasty group had an average EQ-5D score of 0·90 (SD 0·16), compared with 0·89 (SD 0·18) in the eye drops group…”.

Click here to view the full article which appeared in The Lancet